GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Dividend Yield %

INBX (Inhibrx Biosciences) Dividend Yield % : 0.00% (As of Mar. 16, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences Dividend Yield %?

As of today (2025-03-16), the Trailing Annual Dividend Yield of Inhibrx Biosciences is 0.00%.

The historical rank and industry rank for Inhibrx Biosciences's Dividend Yield % or its related term are showing as below:

INBX's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.425
* Ranked among companies with meaningful Dividend Yield % only.

Inhibrx Biosciences's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00.

As of today (2025-03-16), the Forward Dividend Yield % of Inhibrx Biosciences is 0.00%.

Inhibrx Biosciences's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Inhibrx Biosciences Dividend Yield % Historical Data

The historical data trend for Inhibrx Biosciences's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences Dividend Yield % Chart

Inhibrx Biosciences Annual Data
Trend Dec22 Dec23
Dividend Yield %
- -

Inhibrx Biosciences Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Inhibrx Biosciences's Dividend Yield %

For the Biotechnology subindustry, Inhibrx Biosciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inhibrx Biosciences's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inhibrx Biosciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Inhibrx Biosciences's Dividend Yield % falls into.



Inhibrx Biosciences Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Inhibrx Biosciences  (NAS:INBX) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Inhibrx Biosciences Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Inhibrx Biosciences Business Description

Traded in Other Exchanges
N/A
Address
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.